The company will publish the clinical study data of the innovation research of OBI-822/OBI-821 for metastatic breast cancer patients at the annual meeting of 2016 ASCO.

1.Date of occurrence of the event:2016/06/05 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliatecompany”): The Company head office 4.Reciprocal shareholding ratios: N/A 5.Name of mass media: N/A 6.Content reported: N/A 7.Cause of occurrence: The description of the press conference held in Taipei exchange at 10:30 am, today (6/5): […]

This article is password protected.

To view the content, please enter your password in the field below